Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Ph-Sensitive Biocompatible Mesoporous Magnetic Nanoparticles Labeled With Folic Acid As an Efficient Carrier for Controlled Anticancer Drug Delivery Publisher



Avedian N1 ; Zaaeri F2 ; Daryasari MP3 ; Akbari Javar H2 ; Khoobi M3, 4
Authors
Show Affiliations
Authors Affiliations
  1. 1. Tehran University of Medical Sciences, International Campus (TUMS-IC), Tehran, Iran
  2. 2. Department of Pharmaceutics, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Nanobiomaterials Group, Pharmaceutical Sciences Research Center, Tehran University of Medical Sciences, Tehran, 1417614411, Iran
  4. 4. Department of Pharmaceutical Biomaterials and Medical Biomaterials Research Center, Faculty of Pharmacy, Tehran University of Medical Sciences, P.O. Box 14155–6451, Tehran, 1417614411, Iran

Source: Journal of Drug Delivery Science and Technology Published:2018


Abstract

A qualified nanocarrier for drug delivery to tumor cells based on magnetic mesoporous silica nanoparticles (MMSNs), consisting of Fe3O4 core coated with mesoporous silica and a pH-responsive shell of poly (ethyleneimine) conjugated folic acid was prepared. The nanoparticles were characterized using various techniques including dynamic light scattering (DLS), Brunauer–Emmett–Teller (BET), scanning and transmission electron microscope (SEM and TEM), Fourier transform infrared spectroscopy (FTIR), X-ray diffraction (XRD), thermogravimetric analysis (TGA), and vibrating sample magnetometer (VSM). Erlotinib as a model anticancer drug was loaded and the release profile was evaluated at pH of 5.5 and 7.4 during 4 days. At lower pH, Erlotinib release amount increased to 63% in comparison with 33% at normal pH. Hemolysis assay results confirmed negligible hemolytic activity of the prepared nanoparticles. No significant toxicity was observed for Erlotinib free MMSNs, while the Erlotinib loaded MMSNs inhibited proliferation of HeLa cell lines. Furthermore, folic acid labeled nanoparticles showed higher cytotoxicity effect on cancerous HeLa cells. Accordingly, the results suggest a controlled targeted drug delivery system to decrease the side effects of anti-cancer drugs. © 2018 Elsevier B.V.
Related Docs
View other Related Docs
1. Glutathione Conjugated Polyethylenimine on the Surface of Fe 3 O 4 Magnetic Nanoparticles As a Theranostic Agent for Targeted and Controlled Curcumin Delivery, Journal of Biomaterials Science# Polymer Edition (2018)
2. Polyethylenimine-Graft-Poly (Maleic Anhydride-Alt-1-Octadecene) Coated Fe3o4 Magnetic Nanoparticles: Promising Targeted Ph-Sensitive System for Curcumin Delivery and Mr Imaging, International Journal of Polymeric Materials and Polymeric Biomaterials (2021)
3. Folate-Conjugated Nanoparticles As a Potent Therapeutic Approach in Targeted Cancer Therapy, Tumor Biology (2015)
4. Smart Internal Stimulus-Responsive Nanocarriers for Drug and Gene Delivery, Smart internal stimulus-responsive nanocarriers for drug and gene delivery (2015)
5. Folic Acid Decorated Magnetic Nanosponge: An Efficient Nanosystem for Targeted Curcumin Delivery and Magnetic Resonance Imaging, Journal of Colloid and Interface Science (2019)
6. Evaluation of Targeted Curcumin (Cur) Loaded Plga Nanoparticles for in Vitro Photodynamic Therapy on Human Glioblastoma Cell Line, Photodiagnosis and Photodynamic Therapy (2018)
7. Double Domain Polyethylenimine-Based Nanoparticles for Integrin Receptor Mediated Delivery of Plasmid Dna, Scientific Reports (2018)
8. A Biocompatible Theranostic Nanoplatform Based on Magnetic Gadolinium-Chelated Polycyclodextrin: In Vitro and in Vivo Studies, Carbohydrate Polymers (2021)
Experts (# of related papers)
View all Related Experts
Mehdi Khoobi (11)
Sadegh Dehghani (4)
Other Related Docs
9. Silk Fibroin Nanoparticle As a Novel Drug Delivery System, Journal of Controlled Release (2015)
10. Multifunctional Mil-Cur@Fc As a Theranostic Agent for Magnetic Resonance Imaging and Targeting Drug Delivery: In Vitro and In Vivo Study, Journal of Drug Targeting (2020)
11. Glucosamine Conjugated Gadolinium (Iii) Oxide Nanoparticles As a Novel Targeted Contrast Agent for Cancer Diagnosis in Mri, Journal of Biomedical Physics and Engineering (2020)
12. Glyco-Nanoparticles: New Drug Delivery Systems in Cancer Therapy, Seminars in Cancer Biology (2021)
13. Theranostic Α-Lactalbumin-Polymer-Based Nanocomposite As a Drug Delivery Carrier for Cancer Therapy, ACS Biomaterials Science and Engineering (2019)
14. Rgd-Engineered Nanoparticles As an Innovative Drug Delivery System in Cancer Therapy, Journal of Drug Delivery Science and Technology (2023)
15. Future Perspective on the Smart Delivery of Biomolecules, Drug Delivery Systems (2017)
16. Green Synthesis of Magnetic Fe3o4/Sio2/Hap Nanocomposite for Atenolol Delivery and in Vivo Toxicity Study, Journal of Cleaner Production (2017)
17. Enhancement Antimicrobial Activity of Clarithromycin by Amine Functionalized Mesoporous Silica Nanoparticles As Drug Delivery System, Letters in Drug Design and Discovery (2018)
18. Gadolinium (Iii) Oxide Nanoparticles Coated With Folic Acid-Functionalized Poly(Β-Cyclodextrin-Co-Pentetic Acid) As a Biocompatible Targeted Nano-Contrast Agent for Cancer Diagnostic: In Vitro and in Vivo Studies, Magnetic Resonance Materials in Physics# Biology and Medicine (2019)
19. Does Pharmacodynamics of Drugs Change After Presenting Them As Na-Noparticles Like Their Pharmacokinetics?, Current Drug Targets (2020)
20. Chitosan/Agarose-Encapsulated Oleic Acid-Coated Magnetite Nanoparticles As a Chemotherapeutic-Loaded Scaffold for Drug Delivery: Physico-Chemical and in Vitro Biological Characteristics, International Journal of Biological Macromolecules (2025)
21. Classification of Stimuli-Responsive Polymers As Anticancer Drug Delivery Systems, Drug Delivery (2015)
22. Curcumin-Lipoic Acid Conjugate As a Promising Anticancer Agent on the Surface of Gold‑Iron Oxide Nanocomposites: A Ph-Sensitive Targeted Drug Delivery System for Brain Cancer Theranostics, European Journal of Pharmaceutical Sciences (2018)